| 13:00 Uhr Dr. Hannes VIETZEN, MSc „Virologie“ | HCMV-specific NKG2C+natural killer cells: Friend or foe in lung-transplant recipients |
| 13:20 Uhr Ass.-Prof. Mag. Thomas STEINKELLNER, PhD „Pharmakologie und Toxikologie“ | Molecular pharmacology and toxicology of dopamine neuron vulnerability |
| 13:40 Dr. Hossein TAGHIZADEH, PhD MSc “Klinische Onkologie” | Applied precision medicine in modern oncology |